Funding for this research was provided by:
National Center for Complementary and Integrative Health (T32 A T004094)
National Institute of General Medical Sciences (1 U54 GM104940)
Article History
First Online: 16 July 2018
Compliance with ethical standards
:
: Frank Greenway has served on the advisory boards for BAROnova, Eisai Inc., Curves, Novo Nordisk, Microbiome Therapeutics, Orexigen, Pamlab, PlenSat, Zaluvida and Zafgen. He has consulted for Basic Research, General Nutrition Corporation, Neothetics, Takeda, and Tech Enterprises.